ArticleData in brief2018
Data on leukocyte PDZK1 deficiency affecting macrophage apoptosis but not monocyte recruitment, cell proliferation, macrophage abundance or ER stress in atherosclerotic
Article in Data in brief, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 7 citations in OpenAlex.
- Apolipoprotein A1 deficiency increases macrophage apoptosis and necrotic core development in atherosclerotic plaques in a Bim-dependent manner.Journal of lipid research · 2025Article
- Article
- Endoplasmic Reticulum Stress in Macrophages: The Vicious Circle of Lipid Accumulation and Pro-Inflammatory Response.Biomedicines · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PDZK1 (Post-synaptic density protein/Drosophila disc-large protein/Zonula occludens protein containing 1) is an adaptor protein that binds to the HDL receptor, Scavenger receptor class B type I. Leukocyte PDZK1 deficiency in high fat-diet fed LDL receptor knockout mice has been found to increase atherosclerotic necrotic core formation and apoptosis of cells within atherosclerotic plaques. To explore mechanisms that may be involved, we examined the effects of leukocyte PDZK1 deficiency in mice on a number of processes that may impact macrophage abundance within atherosclerotic plaques. We found that leukocyte PDZK1 deficiency in high fat diet fed LDL receptor knockout mice did not affect the abundance of circulating red blood cells, myeloid cells or B- or T-lymphocytes. Leukocyte selective PDZK1 deficiency did not affect the levels of the ER chaperone proteins, detected with an antibody against the KDEL peptide, in macrophages or macrophage abundance, cellular proliferation or monocyte recruitment in atherosclerotic plaques. Leukocyte PDZK1 deficiency in otherwise wild type mice did result in increased sensitivity of macrophages to tunicamycin-induced apoptosis in a peritonitis model. HDL protected wild type macrophages from apoptosis induced by a variety of agents, including the ER stressor tunicamycin, oxidized LDL and exposure to UV irradiation. However, this protection afforded by HDL was lost when macrophages were deficient in PDZK1. HDL did not affect the level of ER stress induction by tunicamycin. Finally, PDZK1 deficiency in macrophages did not affect lipopolysaccharide-mediated induction of markers of M1 polarization. These data, utilizing mouse and cellular models, help to demonstrate that leukocyte PDZK1 plays a role in atherosclerosis by affecting macrophage apoptosis within atherosclerotic plaques.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.